Shitaoka K, Higashiura A, Kawano Y, Yamamoto A, Mizoguchi Y, Hashiguchi T, et al. Structural basis of spike RBM-specific human antibodies counteracting broad SARS-CoV-2 variants. Commun Biol. 2023;6:395 pubmed publisher

Kroll M, Schloer S, Candan P, Korthals N, Wenzel C, Ihle H, et al. Importance of ACE2 for SARS-CoV-2 Infection of Kidney Cells. Biomolecules. 2023;13: pubmed publisher

Palermo E, Alexandridi M, Di Carlo D, Muscolini M, Hiscott J. Virus-like particle - mediated delivery of the RIG-I agonist M8 induces a type I interferon response and protects cells against viral infection. Front Cell Infect Microbiol. 2022;12:1079926 pubmed publisher

Azuma H, Kawano Y, Shitaoka K, Kawahara T, Ito A, Higashiura A, et al. Vaccination with the Omicron spike RBD boosts broadly neutralizing antibody levels and confers sustained protection even after acquiring immunity to the original antigen. Int Immunol. 2022;: pubmed publisher

Faizan M, Chaudhuri R, Sagar S, Albogami S, Chaudhary N, Azmi I, et al. NSP4 and ORF9b of SARS-CoV-2 Induce Pro-Inflammatory Mitochondrial DNA Release in Inner Membrane-Derived Vesicles. Cells. 2022;11: pubmed publisher

Xu C, Wang A, Marin M, Honnen W, Ramasamy S, Porter E, et al. Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry. Viruses. 2021;13: pubmed publisher

Mishra T, Sreepadmanabh M, Ramdas P, Sahu A, Kumar A, Chande A. SARS CoV-2 Nucleoprotein Enhances the Infectivity of Lentiviral Spike Particles. Front Cell Infect Microbiol. 2021;11:663688 pubmed publisher